Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
Top Cited Papers
- 1 February 2014
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 146 (2), 392-400.e3
- https://doi.org/10.1053/j.gastro.2013.10.052
Abstract
No abstract availableKeywords
Funding Information
- Schering-Plough
- Merck
This publication has 17 references indexed in Scilit:
- Efficacy and safety of infliximab as continuous or intermittent therapy in patients with moderate-to-severe plaque psoriasis: results of a randomized, long-term extension trial (RESTORE2)British Journal of Dermatology, 2013
- Ulcerative ColitisThe New England Journal of Medicine, 2011
- Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters CommitteeThe American Journal of Gastroenterology, 2010
- European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosisJournal of Crohn's and Colitis, 2008
- European evidence-based Consensus on the management of ulcerative colitis: Current managementJournal of Crohn's and Colitis, 2008
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisThe New England Journal of Medicine, 2005
- Medical therapy for ulcerative colitis 2004Gastroenterology, 2004
- The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based studyGastroenterology, 2001
- Quality of life: A valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel diseaseGastroenterology, 1994
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisThe New England Journal of Medicine, 1987